Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
6 TWD
−623.84 M TWD
5.11 B TWD
284.20 M
About PHARMAESSENTIA CORP
Sector
CEO
Kuo Chung Lin
Headquarters
Taipei
Website
Founded
2000
ISIN
TW0006446008
FIGI
BBG0063GF1Z0
PharmaEssentia Corp. engages in the research, development, production and sale of drugs. Its business activities include the manufacture and sale of therapeutic products for the treatment of human diseases. The company was founded by Kuo Chung Lin on May 9, 2000 and is headquartered in Taipei, Taiwan.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 6446 is 602 TWD — it has decreased by −0.33% in the past 24 hours. Watch PHARMAESSENTIA CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TWSE exchange PHARMAESSENTIA CORP stocks are traded under the ticker 6446.
6446 stock has risen by 4.88% compared to the previous week, the month change is a 10.05% rise, over the last year PHARMAESSENTIA CORP has showed a 86.67% increase.
We've gathered analysts' opinions on PHARMAESSENTIA CORP future price: according to them, 6446 price has a max estimate of 888.00 TWD and a min estimate of 741.00 TWD. Watch 6446 chart and read a more detailed PHARMAESSENTIA CORP stock forecast: see what analysts think of PHARMAESSENTIA CORP and suggest that you do with its stocks.
6446 reached its all-time high on Sep 23, 2024 with the price of 735 TWD, and its all-time low was 281 TWD and was reached on Apr 19, 2024. View more price dynamics on 6446 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
6446 stock is 2.33% volatile and has beta coefficient of 0.42. Track PHARMAESSENTIA CORP stock price on the chart and check out the list of the most volatile stocks — is PHARMAESSENTIA CORP there?
Today PHARMAESSENTIA CORP has the market capitalization of 201.06 B, it has increased by 5.94% over the last week.
Yes, you can track PHARMAESSENTIA CORP financials in yearly and quarterly reports right on TradingView.
PHARMAESSENTIA CORP is going to release the next earnings report on Mar 3, 2025. Keep track of upcoming events with our Earnings Calendar.
6446 earnings for the last quarter are 2.21 TWD per share, whereas the estimation was 2.29 TWD resulting in a −3.49% surprise. The estimated earnings for the next quarter are 2.69 TWD per share. See more details about PHARMAESSENTIA CORP earnings.
PHARMAESSENTIA CORP revenue for the last quarter amounts to 2.71 B TWD, despite the estimated figure of 2.74 B TWD. In the next quarter, revenue is expected to reach 2.96 B TWD.
6446 net income for the last quarter is 719.69 M TWD, while the quarter before that showed 679.82 M TWD of net income which accounts for 5.86% change. Track more PHARMAESSENTIA CORP financial stats to get the full picture.
No, 6446 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 560.00 employees. See our rating of the largest employees — is PHARMAESSENTIA CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PHARMAESSENTIA CORP EBITDA is 1.44 B TWD, and current EBITDA margin is −32.21%. See more stats in PHARMAESSENTIA CORP financial statements.
Like other stocks, 6446 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PHARMAESSENTIA CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PHARMAESSENTIA CORP technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PHARMAESSENTIA CORP stock shows the strong buy signal. See more of PHARMAESSENTIA CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.